Japanese Capital Markets Stock News

Mitsubishi Heavy Industries stock: new exposure to commercial space ventures Mitsubishi Heavy Industries (TSE:7011) has taken part in funding Japan LEO Shachu, a space venture working on post International Space Station platforms. This provides shareholders with fresh exposure to potential commercial low Earth orbit projects. See our latest analysis for Mitsubishi Heavy Industries. The Japan LEO Shachu funding comes after a mixed few months for Mitsubishi Heavy Industries, with a 14.58% 1...

Why Shochiku’s upgraded guidance matters for investors Shochiku (TSE:9601) raised its earnings guidance for the fiscal year ending February 2026, highlighting stronger than previously expected profit contributions from its motion pictures and theatre businesses, as well as higher margin broadcasting rights sales. See our latest analysis for Shochiku. The upgraded guidance comes after a softer run in the share price. Shochiku’s 90 day share price return of 5.99% and year to date share price...

Why Komatsu (TSE:6301) is on investors’ radar today Komatsu (TSE:6301) has attracted fresh attention after a solid year of share price performance, with a 1 year total return of 27.6% and a 3 year total return above 100%. See our latest analysis for Komatsu. At a share price of ¥5,639, Komatsu’s recent 30 day share price return of 12.76% and 1 year total shareholder return of 27.57% suggest momentum has been building rather than fading, on top of already strong multi year gains. If Komatsu’s...

Japan Hotel REIT Investment (TSE:8985) is back in focus after raising its full year 2025 earnings and dividend forecasts, while also laying out fresh 2026 guidance and publishing December 2025 operating figures. See our latest analysis for Japan Hotel REIT Investment. At a share price of ¥83,000, Japan Hotel REIT Investment has seen mixed recent momentum, with a 1 month share price return of 1.10% but a 3 month decline of 8.49%. Its 1 year total shareholder return of 21.29% and 5 year total...

Wondering whether SoftBank Group's current share price lines up with its actual worth, or if the market is getting ahead of itself? This article walks through what the numbers are really saying about value. SoftBank Group last closed at ¥4,187, with a 7 day return of 8.1%, a 30 day return of a 6.6% decline, a year to date return of a 9.3% decline, and a 1 year return of 78.9%, alongside a 172.3% return over 3 years and 98.2% over 5 years. Recent headlines have focused heavily on SoftBank...

As global markets navigate a volatile landscape marked by geopolitical tensions and economic shifts, investors are keenly observing the performance of major indices. With U.S. economic growth showing resilience despite inflationary pressures and European markets grappling with trade uncertainties, dividend stocks continue to attract attention for their potential to provide steady income amid market fluctuations. In such an environment, a good dividend stock typically offers consistent payouts...

The board of Shin-Etsu Chemical Co., Ltd. ( TSE:4063 ) has announced that it will pay a dividend of ¥53.00 per share on...

Most readers would already know that Yamazaki Baking's (TSE:2212) stock increased by 9.2% over the past three months...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Most readers would already know that Hikari Tsushin's (TSE:9435) stock increased by 5.3% over the past three months...

Asahi Kasei, Mitsui Chemicals, and Mitsubishi Chemical previously agreed to form a joint operating entity to consolidate ethylene production in western Japan, backed by Japan’s HtA Support Program and a ¥21.20 billion investment to shift toward biomass-based and lower-emission processes. By pairing facility consolidation with Asahi Kasei’s Revolefin™ technology and a government subsidy of up to ¥10.40 billion, the alliance targets meaningful carbon footprint reductions and a new pathway for...

In January 2026, Rakuten Bank’s board approved issuing stock options covering up to 31,900 shares to 316 employees and launched a promotional 1.00% 1-year fixed deposit campaign that is drawing funds from ordinary accounts. Together, these moves highlight a dual focus on long-term staff retention and near-term deposit growth, while potentially lifting funding costs and affecting profitability metrics. We’ll now examine how the new stock option program for employees shapes Rakuten Bank’s...

It is hard to get excited after looking at Kobe Bussan's (TSE:3038) recent performance, when its stock has declined...

C.Uyemura & Co.,Ltd. ( TSE:4966 ), is not the largest company out there, but it received a lot of attention from a...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Key Insights Significant control over Life by individual investors implies that the general public has more power to...

Key Insights Institutions' substantial holdings in IbidenLtd implies that they have significant influence over the...

Most readers would already be aware that SWCC's (TSE:5805) stock increased significantly by 59% over the past three...

Buying shares in the best businesses can build meaningful wealth for you and your family. While not every stock...

In January 2026, KDDI Corporation’s board met to address suspicions of inappropriate transactions at its consolidated subsidiaries and approved the formation of a special investigation committee. The move shines a spotlight on KDDI’s governance framework and internal controls, as investors assess how rigorously the company responds to these concerns. Next, we’ll examine how the investigation into inappropriate subsidiary transactions shapes KDDI’s investment narrative and risk considerations...

INFRONEER Holdings Inc.'s ( TSE:5076 ) price-to-earnings (or "P/E") ratio of 12.7x might make it look like a buy right...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you buy shares in a...

Fanuc (TSE:6954) has laid out its Q3 2026 scorecard with revenue of ¥215.7b and basic EPS of ¥39.70, set against a trailing twelve month line of ¥835.4b in revenue and EPS of ¥173.21. Over recent quarters, the company has seen revenue move from ¥197.1b in Q3 2025 to ¥212.1b in Q4 2025, ¥196.4b in Q1 2026, ¥211.2b in Q2 2026 and now ¥215.7b in Q3 2026. Quarterly EPS shifted from ¥35.21 to ¥47.97, ¥40.56, ¥44.98 and ¥39.70 across the same period, which may prompt investors to focus on how its...

Daiichi Sankyo recently gained approval in China for ENHERTU as the first HER2-directed antibody-drug conjugate for second-line treatment of HER2 positive metastatic gastric cancer, while also advancing its ADC pipeline and transitioning leadership at its Translational Research Center Europe. This approval taps into China’s large gastric cancer burden and underscores the central role of Daiichi Sankyo’s DXd ADC platform in its oncology franchise. We’ll now examine how ENHERTU’s new gastric...